Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Espelin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|December 8, 2009
DataPflex: a MATLAB-based tool for the manipulation and visualization of multidimensional datasetsBart S Hendriks, Christopher W Espelin
The Journal of Cell Biology|February 11, 2004
Spindle checkpoint proteins and chromosome-microtubule attachment in budding yeastEmily S Gillett, Christopher W Espelin, Peter K Sorger
Molecular Biology of the Cell|September 19, 2003
Binding of the essential Saccharomyces cerevisiae kinetochore protein Ndc10p to CDEIIChristopher W Espelin, Kim T Simons, Stephen C Harrison, et al.
Cancer Research|January 14, 2016
Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric CancerChristopher W Espelin, Shannon C Leonard, Elena Geretti, et al.
Molecular Biosystems|July 10, 2010
Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell lineChristopher W Espelin, Arthur Goldsipe, Peter K Sorger, et al.
Molecular Cancer Therapeutics|June 1, 2013
Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effectBart S Hendriks, Stephan G Klinz, Joseph G Reynolds, et al.
Molecular Cancer Therapeutics|July 12, 2015
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)Elena Geretti, Shannon Curtis Leonard, Nancy Dumont, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|December 8, 2009
DataPflex: a MATLAB-based tool for the manipulation and visualization of multidimensional datasetsBart S Hendriks, Christopher W Espelin
The Journal of Cell Biology|February 11, 2004
Spindle checkpoint proteins and chromosome-microtubule attachment in budding yeastEmily S Gillett, Christopher W Espelin, Peter K Sorger
Molecular Biology of the Cell|September 19, 2003
Binding of the essential Saccharomyces cerevisiae kinetochore protein Ndc10p to CDEIIChristopher W Espelin, Kim T Simons, Stephen C Harrison, et al.
Cancer Research|January 14, 2016
Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric CancerChristopher W Espelin, Shannon C Leonard, Elena Geretti, et al.
Molecular Biosystems|July 10, 2010
Elevated GM-CSF and IL-1beta levels compromise the ability of p38 MAPK inhibitors to modulate TNFalpha levels in the human monocytic/macrophage U937 cell lineChristopher W Espelin, Arthur Goldsipe, Peter K Sorger, et al.
Molecular Cancer Therapeutics|June 1, 2013
Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effectBart S Hendriks, Stephan G Klinz, Joseph G Reynolds, et al.
Molecular Cancer Therapeutics|July 12, 2015
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)Elena Geretti, Shannon Curtis Leonard, Nancy Dumont, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2019
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironmentNancy Dumont, Samantha Merrigan, Jason Turpin, et al.
Pageof 1